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Abstract
Background: Eosinophilic granulocytes are important for the human immune system. Many cationic proteins with
cytotoxic activities, such as eosinophil cationic protein (ECP) and eosinophil-derived neurotoxin (EDN), are released
from activated eosinophils. ECP, with low RNase activity, is widely used as a biomarker for asthma. ECP inhibits cell
viability and induces apoptosis to cells. However, the specific pathway underlying the mechanisms of ECP-induced
cytotoxicity remains unclear. This study investigated ECP-induced apoptosis in bronchial epithelial BEAS-2B cells
and elucidated the specific pathway during apoptosis.
Results: To address the mechanisms involved in ECP-induced apoptosis in human BEAS-2B cells, investigation was
carried out using chromatin condensation, cleavage of poly (ADP-ribose) polymerase (PARP), sub-G1 distribution in
cell cycle, annexin V labeling, and general or specific caspase inhibitors. Caspase-8-dependent apoptosis was
demonstrated by cleavage of caspase-8 after recombinant ECP treatment, accompanied with elevated level of
tumor necrosis factor alpha (TNF-a). Moreover, ECP-induced apoptosis was effectively inhibited in the presence of
neutralizing anti-TNF-a antibody.
Conclusion: In conclusion, our results have demonstrated that ECP increased TNF-a production in BEAS-2B cells
and triggered apoptosis by caspase-8 activation through mitochondria-independent pathway.
Background
Eosinophilic granulocytes, commonly called eosinophils,
are leukocytes that develop in the bone marrow and dif-
ferentiate from hematopoietic progenitor cells [1]. Eosi-
nophils traffic into tissues, such as the gastrointestinal,
genitourinary and respiratory tracts [2], and are
recruited to airway tissues during the asthmatic inflam-
matory process [3]. Activated eosinophils release cyto-
kines such as tumor necrosis factor alpha (TNF-a)[ 1 ]
and granular toxic proteins. Among which eosinophil
cationic protein (ECP) and eosinophil-derived neuro-
toxin (EDN) share 67% amino acid sequence identity [4]
and play important roles in the pathogenesis of mam-
malian cells [5].
ECP is a member of the pancreatic-type extracellular
ribonuclease (RNase) family, in which ECP and EDN are
respectively named as RNase3 and RNase2 [6]. It has
been extensively investigated as an efficacious biomarker
of airway inflammation such as asthma [7] and has been
suggested as a causal factor in allergic respiratory dis-
ease [8]. ECP is a potent cytotoxic protein capable of
killing cells of guinea pig tracheal epithelium [9], mam-
malian leukemia [10], epidermis carcinoma [9], and
breast carcinoma [11] as well as non-mammalian cells
such as parasites, bacteria,a n dv i r u s e s[ 1 2 ] .T h em o l e -
cular mechanisms of ECP cytotoxicity are not involved
in its RNase activity [13]. Interestingly, we have pre-
viously shown that the signal peptide of ECP is toxic to
cells lacking of the signal peptide peptidase, an intra-
membrane protease located in the endoplasmic reticu-
lum (ER) [14] and it also triggers up-regulation of trans-
forming growth factor alpha (TGF-a)e x p r e s s i o ni n
human cells [15]. Mature ECP devoid of the 27-residue
signal peptide contains 133 residues with high positive
charges [16]. Cellular uptake and cytotoxicity of RNases
have been correlated with the pI value and positive
charge [17,18]. We have recently reported that mature
ECP is cytotoxic to human bronchial epithelial (BEAS-
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fate proteoglycans (HSPGs) followed by endocytosis
[19,20].
M a n yR N a s e s ,s u c ha sE D N ,O n c o n a s e( O N C ) ,a n d
ECP have been reported to induce apoptosis in cells
[21-23]. In one such study, a synthetic peptide of EDN
was found to induce apoptosis in Kaposi’s sarcoma cells
[22]. Moreover, ONC, one member of bullfrog RNase A
superfamily, displays apoptosis to tumor cells [23]. A
latest study indicated that ECP caused cytotoxicity in
HL-60 and HeLa cells via caspase-3 like activity [21].
Accordingly, cytotoxic RNases play an important role in
cell death. However, the mechanism of ECP-induced
apoptosis is still not fully verified. Recent studies have
shown that eosinophils can induce epithelial cell death
via apoptosis and necrosis [24]. In addition, apoptosis of
airway epithelium cells (AECs) has been reported as a
mechanism for removing damaged cells to maintain
AEC function such as immune and inflammatory modu-
lators [25,26]. It has also been suggested that AECs in
response to different external invasions (e.g., pathogens)
can protect themselves [25]. However, the specific apop-
tosis pathway in ECP-induced human AEC death
remains unclear.
Apoptosis, also called programmed cell death, is gen-
erally distinguished into two types–caspase-dependent
and caspase-independent [27,28]–with the former being
the major type. Caspases belong to the cysteinyl aspar-
tate protease family and are classified as effectors (cas-
pases-3, -7, and -6) and initiators (caspases-2, -8, -9, and
-10) of programmed cell death. In addition, caspase-12
is reported to be an inflammatory caspase [29]. Cur-
rently caspase-dependent apoptosis is divided into three
pathways: two intrinsic mitochondria- and ER-associated
pathways [30,31] and one extrinsic death receptor-
initiated pathway [32]. Mitochondrial membrane poten-
tial (MMP) represents a crucial check-point involving
caspase-9, which leads to apoptosis [33]. A current
study showed that ER stress response involved in cas-
pase-12 could induce apoptosis [34], and consequently
the ER stress-induced chaperones such as 78-kDa glu-
cose-regulated protein (GRP78) were activated to rescue
the cells. GRP78 inhibits apoptotic signaling through ER
or non-ER stress [35]. Caspase-8-dependent apoptosis
m a yb et r i g g e r e db yc e l ls u r f a ce receptors belonging to
the tumor gene superfamily, including CD95 (or Fas)
[36,37], TNF receptor-1 (TNFR1) [38], and TNF-related
apoptosis-inducing ligand (TRAIL) [39,40]. Another
mechanism for initiating the proteolytic cascade is
induced by engagement of TNFR, Fas/APO-1/CD95,
triggering caspase-3 activation by activated-caspase-8
without involvement of mitochondria [41,42]. Regarding
the ligand of TNFR, TNF-a, it has been reported to be
released from epithelial cells [43] and activated
eosinophils [44]. Moreover, it is known that poly (ADP-
ribose) polymerase (PARP) is cleaved by caspase-3, a
downstream caspase of caspase-8, -9, and -12, and
causes cell apoptosis [45].
In general, asthma patients have a higher concentra-
tion of ECP in serum, bronchoalveolar lavage, and spu-
tum, along with tissue damage than healthy people
[46-48]. Severe damage and shedding are commonly
observed in asthmatic airway epithelium [49]. Therefore,
understanding the mechanism of ECP-induced apoptosis
might provide practical methods to treat asthma. Here
we intended to determine if BEAS-2B cell death
occurred primarily due to apoptosis after ECP treat-
ments, and verified the pathway involved in apoptotic
cells.
Results
rECP causes cell death and apoptosis
The effect of rECP on BEAS-2B cell viability was deter-
mined by the MTT assay. The rECP was added to the
cell culture at concentrations of 0, 10, 20, 30, 40 and 50
μM at 37°C for 48 h. rECP inhibited cell viability with
an IC50 of 21.03 μM, and cell viability was rescued by
general caspase inhibitor, Z-VAD-FMK (Figure 1A).
After co-incubation with rECP, shrinkage and unattach-
ment of the cells from culture plate were observed (Fig-
ure 1B). BEAS-2B is a human bronchial epithelial cell
line which is quite similar to primary cell. To determine
whether such cell death was related to apoptosis, the
nuclei were stained with Hoechst 33342 to monitor con-
densation of nuclear chromatin. Bright spots in the
rECP-treated cells indicated nuclei undergoing chroma-
tin condensation, strongly suggesting that BEAS-2B cells
underwent apoptosis (Figure 1C). Here, apoptosis was
also evaluated by staining with annexin V, a reagent
commonly used to detect early apoptosis. BEAS-2B cells
were treated with 20 μM rECP for 24 h. The treated
BEAS-2B cells showed 14.5 ± 0.1% apoptosis (Figure
1D). Besides, the characteristic DNA fragmentation
upon treatment with rECP was observed (Additional file
1). In comparison with untreated cells, the data indi-
cated that BEAS-2B cells underwent early apoptosis
after treatment with rECP.
rECP alters cell cycle distribution in BEAS-2B cells
DNA damage is a general phenomenon in apoptotic
cells and usually determined by sub-G1 cell cycle pro-
gression. To investigate whether caspase-9 and -12, mar-
kers of mitochondria and ER, respectively, were
activated in BEAS-2B cells, specific pathway inducers
were used as alternative apoptotic initiators for compari-
son. BEAS-2B cells were treated separately with 0.1 μM
staurosporin (STS), a strong mitochondrial damage
inducer, and 1 μM thapsigargin (TG), a strong ER
response inducer, for 24 h and stained with PI prior to
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activated cell sorting (FACS) (Figure 2). The fraction of
untreated control cells in sub-G1 was 2%, and that of
cells treated with STS, rECP and TG was increased sig-
nificantly up to 36%, 9% and 7%. Therefore, the increase
of sub-G1 fraction in the individual treatments repre-
sented the cells undergoing apoptosis. Here TG and
S T Sw e r ea b l et oi n d u c ea p o p t o s i si nB E A S - 2 Bc e l l s
through the ER response and mitochondrial damage
pathways, respectively.
rECP induces apoptosis in a caspase-dependent manner
In general, activation of the caspase cascade plays an
important role in apoptosis. To identify possible involve-
ment of caspases in ECP-induced apoptosis, BEAS-2B
cells were treated with rECP in the presence or absence
of general caspase inhibitor Z-VAD-FMK and specific
caspase-9 and -12 inhibitors, Z-LE(OMe)HD(OMe)-
FMK and Z-ATAD-FMK, respectively. The presence of
cleaved poly (ADP-ribose) polymerase (PARP) was mon-
itored to evaluate the degree of apoptosis. As compared
with the control cells without drug treatment, apoptosis
was clearly blocked by caspase inhibitors. The levels of
cleaved PARP decreased 92% upon pre-treatment with
Z-VAD-FMK (Figure 3A), suggesting that ECP-induced
apoptosis proceeded via the caspase-dependent pathway.
However, cells pre-treated with Z-LE(OMe)HD(OMe)-
Figure 1 Effect of rECP on the viability of BEAS-2B cells. BEAS-
2B cells (5 × 10
3) were incubated in a 96-well plate and treated
with various concentrations of rECP as indicated for 48 h. Cell
viability was determined by the MTT assay. (A) Cells were treated
with rECP (up to 50 μM) for 48 h in the presence or absence of the
general caspase inhibitor Z-VAD-FMK. (B) Morphology of the cells
treated with serial concentrations of rECP ranging from 0 to 50 μM
(concentrations shown below each panel). (C) Nuclei of BEAS-2B
cells were stained with Hoechst 33342. Cells were treated or
untreated with 20 μM rECP for 48 h. Stained nuclei were visualized
by fluorescence microscopy. The chromatin condensation is
indicated by bright blue spots shown by white arrows. (D) BEAS-2B
cells were incubated in the presence or absence of 20 μM rECP for
24 h. The cells were stained with annexin-V-FITC and analyzed by
FACS. Intact cells are located in the lower left quadrant. The
apoptotic cells stained by annexin-V-FITC are located in the lower
right quadrants, respectively. All data represent the arithmetic mean
± SEM.
Figure 2 Effect of rECP, staurosporine, and thapsigargin on cell
cycle progression. BEAS-2B cells were incubated in the presence or
absence of 20 μM rECP, 0.1 μM staurosporine (STS) or 1 μM
thapsigargin (TG) for 24 h. Cells were stained by PI, and DNA
content was analyzed by FACS. The proportion of sub-G1 cells was
analyzed in each treatment. All data represent the arithmetic mean
± SEM. *P < 0.05, ***P < 0.001.
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Page 3 of 14FMK (Figure 3B) or Z-ATAD-FMK (Figure 3C) exhib-
ited no effect upon treatment with rECP, suggesting
that caspase-9 and caspase-12 were not the major path-
ways involved in cell death triggered by rECP.
rECP induces ER-independent apoptosis
The ER response is generally triggered by environmental
stress and sometimes leads to apoptosis. Because GRP78
plays a crucial role in the ER response [50], the level of
GRP78 expression in BEAS-2B cells treated with rECP
was assessed by Western blotting and a de novo synth-
esis assay. Accumulated and newly synthesized GRP78
were detected using anti-GRP78 (Figure 4A) and meta-
bolic labeling with [
35S]methionine (Figure 4B), respec-
tively. The ratio of both accumulated and nascent
GRP78 to actin did not change during rECP treatment.
As for positive control, when the cells were treated with
1 μM TG, an ER toxin, a 2- to 4-fold increase in accu-
mulated GRP78 after 4 to 24 h treatment was observed;
moreover, newly synthesized GRP78 revealed a 4- to 6-
fold increase after 4 to 24 h under the same condition.
Taken together, these results implied that rECP-induced
apoptosis was ER-independent, in consistence with the
results of caspase-12 inhibitor treatment (Figure 3C).
rECP-induced apoptosis is not mitochondria-dependent
It has been reported that loss of MMP is involved in
apoptosis [51]. To investigate whether mitochondrial
events were involved in rECP-induced apoptosis, MMP
was measured by staining with MitoTracker (Red
CMXRos) and analyzed by FACS. BEAS-2B cells treated
with 1 μM STS, as a positive control, resulted in 37.9 ±
9% MMP, indicating that approximately 40% of mito-
chondria were damaged. However, cells treated with 20
and 40 μM rECP revealed MMP values of 5.1 ± 1.8%
and 6.1 ± 2.7%, respectively, which did not substantially
differ from the untreated control cells (3.3 ± 0.4%) (Fig-
ure 5). These results suggested that the caspase-9-
dependent mitochondrial apoptotic pathway was not
involved in rECP-induced apoptosis, in agreement with
the results of caspase-9 inhibitor treatment (Figure 3B).
Moreover, cells treated with 10 and 20 μM rECP did
not alter cytochrome c release, strongly suggesting the
notion that rECP did not cause damage in mitochondria
(Additional file 2).
Caspase-8 is involved in rECP-induced apoptosis
Caspase-8 is a downstream target of the death receptor-
initiated pathway [52]. To identify possible involvement
of caspases-8 in ECP-induced apoptosis, BEAS-2B cells
were treated with rECP in the presence or absence of
caspase-8 inhibitor Z-IETD-FMK. The levels of cleaved
PARP decreased 40% upon pre-treatment with Z-IETD-
FMK (Figure 6A), suggesting that ECP-induced apopto-
sis proceeded possibly via the caspase-8-specific
Figure 3 Effect of caspase inhibitors on rECP-induced apoptosis.( A) To investigate the apoptotic pathway, BEAS-2B cells were pretreated
with 20 μM general caspase inhibitor (Z-VAD), respectively, for 30 min before rECP treatment. (B and C) Cells were treated with 20 μM caspase 9
or 12 inhibitor, Z-LE(OMe)HD(OMe)-FMK (Z-LEHD) or Z-ATAD-FMK (Z-ATAD), respectively, for 30 min before rECP treatment. After 48 h incubation
in the presence or absence of 20 μM rECP, total cell lysates were resolved by 10% SDS-PAGE, and relative cleaved PARP was determined by
western blotting with anti-PARP and anti-actin followed by quantitative analysis. All data represent the arithmetic mean ± SEM. ***P < 0.001.
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Page 4 of 14Figure 4 Effect of rECP-induced apoptosis on ER response. BEAS-2B cells were treated with rECP or thapsigargin (TG; an ER toxin as a
positive control) for the indicated times. The cells used to determine the ER response were incubated with 20 μM rECP or 1 μM TG for 0, 4, 8,
12, 16, 20 and 24 h. (A) Total cell lysates were resolved by 10% SDS-PAGE, and the relative accumulated GRP78 was investigated by western
blotting with anti-GRP78 and anti-actin. (B) For de novo proteins synthesis, cells were labeled with [
35S]methionine for 2 h before harvesting.
Equal amounts of labeled cell lysates were resolved by 10% SDS-PAGE followed by quantitative analysis. All data represent the arithmetic mean
± SEM. *P < 0.05.
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during rECP-induced apoptosis, BEAS-2B cells were
treated with 20 μM rECP for 48 h. The presence of spe-
cific cleavage products of caspase-8 and PARP were acti-
vated (Figure 6B), suggesting that these precursors were
activated and rECP-induced apoptosis was indeed
mediated by caspase-8 pathway in BEAS-2B cells.
To confirm that induction of caspase-dependent apop-
tosis was not derived from lipopolysaccharide, a con-
taminant often observed in recombinant proteins
produced in E. coli, rECP was treated with proteinase K
(PNK) prior to addition to BEAS-2B cells. It was clear
that no PARP cleavage was generated in the presence of
either heated rECP or the PNK-treated rECP mixture
(Figure 6C), strongly suggesting that apoptosis was
indeed induced by rECP itself but not by endotoxins or
contaminants in the sample. Moreover, mutant rECP
H15A/K38I/H128A (mECP), devoid of the RNase activ-
ity, also induced apoptosis, in consistent with the
hypothesis that the RNase activity was not essential for
cytotoxicity of ECP [13].
rECP-induced apoptosis is involved in TNF-a response
BEAS-2B cells treated with rECP induced TNF-a pro-
duction and release (Figures 7). Secretion of TNF-a in
the culture medium was monitored in BEAS-2B cells
treated with rECP for periods from 0 to 48 h (Figure
7A), suggesting that TNF-a production in rECP-treated
cells was time-dependent. An ELISA analysis showed
that TNF-a accumulation in cell lysate of BEAS-2B cells
significantly increased in those treated with rECP after
24 h (49.9 ± 0.5 pg/mg total proteins). The maximum of
TNF-a production in the cells reached at 48 h (58.8 ±
0.6 pg/mg total protein). In addition, higher TNF-a
level was detected in the supernatant of BEAS-2B cells
treated with rECP for 48 h than control cells (16.9 ± 0.1
and 4.0 ± 0.6 pg/ml, respectively) (Figure 7B). In this
study, we have found that mutant ECP lacking of RNase
activity (mECP) can also induce TNF-a liberation; how-
ever, there is no significant increase of TNF-a liberation
upon treating with RNase A (Additional file 3).
Previous results showed that eosinophils induced cells to
undergo apoptosis accompanying with increasing TNF-a
production [26]. To exclude the effect of TNF-a in
rECP-induced apoptosis in BEAS-2B cells, an anti-TNF-
a antibody (Ab) was used to deplete TNF-a in the cul-
ture medium. When BEAS-2B cells were pre-treated
with anti-TNF-a Ab, the levels of cleaved PARP signifi-
cantly decreased to 22% (Figure 7C). Taken together, we
have provided the first direct evidence that rECP
induced BEAS-2B cells to produce TNF-a,w h i c hi n
turn leads to apoptosis via caspase-8 dependent
pathway.
Discussion
AECs play an important role in protecting themselves
from external invasion by forming a physical barrier. It
has been reported that concentrations of ECP of the
sputum is positively correlated with airway inflammation
and asthma severity [46], hence higher sputum ECP
concentration up to μM level was detected in asthmatic
patients [7]. The patches of denuded epithelium were
observed in airway biopsies of asthmatic patients [49].
ECP and EDN, having high sequence and structural
similarity, are released from activated eosinophils. They
inhibit the growth of HL-60 cells (human promyelocytic
leukemia cells) [10] and Kaposi’ss a r c o m a sc e l l s[ 5 3 ] .
Figure 5 Effect of rECP-induced apoptosis on MMP. The MMP of
BEAS-2B cells, stained with MitoTracker (Red CMXRos), represents
the percentage of the damage in mitochondria. BEAS-2B cells were
incubated in the absence or presence of 20 μM rECP, 40 μM rECP
or 1 μM staurosporine (STS) for 24 h. After treatment, the MMP of
cells was determined by FACS. We gated M1 for calculation of
intensity shift. All data represent the arithmetic mean ± SEM.
**P < 0.01.
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Page 6 of 14Figure 6 Effect of caspase-8 on rECP-induced apoptosis.( A)
Cells were treated with 20 μM caspase-8 inhibitor (Z-IETD) for 30
min before rECP treatment. After a 48-h incubation in the presence
or absence of 20 μM rECP, total cell lysates were resolved by 10%
SDS-PAGE. Relative cleaved PARP was assessed by western blotting
using anti-PARP and anti-actin followed by quantitative analysis. (B)
BEAS-2B cells were cultured for 48 h in the presence or absence of
20 μM rECP. Total cell lysates were resolved by 15% SDS-PAGE.
Caspase-8 and PARP were analyzed by western blotting using anti-
caspase-8 and anti-PARP. (C) rECP was incubated with proteinase K
(PNK) (250 μg/ml) for 12 h followed by heating in boiling water for
10 min. Cells were treated in the presence or absence of rECP (20
μM), heated PNK (25 μg/ml), heated mixtures (20 μM rECP and 25
μg/ml PNK), and rECP H15A/K38I/H128A mutant (20 μM) for 48 h.
All data represent the arithmetic mean ± SEM. ***P < 0.001.
Figure 7 Effects of TNF-a on rECP-induced apoptosis. BEAS-2B
cells were treated with 20 μM rECP. (A) TNF-a was measured in cell
lysates by rECP treatment for ranging from 0 to 48 h. (B) TNF-a was
measured in cultured supernatant medium by rECP treatment for 48
h. All the TNF-a measurements were determined by ELISA assay. (C)
To investigate the role of TNF-a in rECP-induced apoptosis, BEAS-2B
cells were pretreated with 5 μM anti-TNF-a Ab for 4 h before rECP
treatment. The addition of IgG Ab to the medium of cells was used
as controls in neutralization studies. All data represent the arithmetic
mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001.
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the mechanism has not been fully elucidated [21,22].
Recently, ECP was shown to inhibit the viability of
BEAS-2B cells as analyzed by MTT assay, but it has
never been reported that ECP could cause apoptosis in
BEAS-2B cells. Our results of increase in chromatin
condensation, sub-G1 population, PARP cleavage, and
DNA fragmentation strongly indicate that ECP induces
apoptosis in BEAS-2B cells. The study by Trautmann et
al. showed that rECP-induced cell death via necrosis in
bronchial epithelial cells (ECs), which might be attribu-
ted to high sensitivity to rECP, and all rECP-induced
apoptotic cells activated signals to necrosis in ECs [24].
In addition, the study by Nicotera et al. showed that
apoptosis and necrosis death in cell were often inter-
twines; through apoptosis pathway, caspase activation
could cause necrosis by promoting ion overload [54].
Cell type specific response may account for different
sensitivity to ECP and different stage of cells in our
case. Pre-treatment with general caspase inhibitor
impedes ECP cytotoxicity, suggesting that ECP-induced
apoptosis is caspase-dependent. It has been known that
mitochondrial damage, ER response, and death receptor
activation would trigger caspase-dependent apoptosis.
Hence three specific caspase (caspase-8, -9 and -12)
inhibitors were used to investigate the possible pathways
during such caspase-dependent apoptosis. Most apopto-
sis is linked to mitochondria-related damage, but pre-
treatment with a caspase-9 inhibitor did not show any
effect in our case. MMP and cytochrome c release
experiments also confirmed this point. In addition, pro-
caspase-12 cleavage to form active caspase-12 may take
place if the ER response has been activated [55].
Although the study shows that human caspase-12 is
regarded as a pseudogene because of losing function
with several mutations [56], Saleh et al. have reported
that caspase-12 shows natural polymorphism in ethnic
groups of African descent [57]. In this study, pre-treat-
ment with a caspase-12 inhibitor, metabolite labeling
and Western blotting for GRP78 indicated that rECP
did not affect the ER response. Apparently rECP-
induced apoptosis was not involved in ER response for
the protein level of GRP78 was not altered with or with-
out ECP treatment. Therefore, ECP-induced apoptosis
was neither caspase-9 nor caspase-12 dependent. Alter-
natively, the death receptor pathway which undergoes
caspase-8 signal transduction, might be involved in
ECP-induced apoptosis. Caspase-8-dependent apoptosis
may be triggered by cell surface death receptors such as
TNFR and Fas...etc. [32]. Till now activation of the cas-
pase-8 pathway in cells treated by eosinophils has never
been reported. Recently, ECP was proved to induce
apoptosis undergoing caspase-3 like pathway [21]. How-
ever, no correlation with caspase-8 has been mentioned.
In this study pre-treatment with caspase-8 inhibitor
clearly demonstrated that apoptosis was mediated
through caspase-8 activation, and cleavage of caspase-8
offered strong evidence to support this notion. This is
the first study showing direct correlation between rECP
and caspase-8 activation in bronchial epithelial cells,
which in turn results in cell apoptosis.
TNF-a or FasL may serve as the death ligands to
AECs during caspase-8-dependent apoptosis and TNF-a
has been reported to induce apoptosis in AECs [26]. It
has also been known that both ECP and TNF-a are
released from activated eosinophils [26] Epithelial cells
release cytokines and growth factors such as IL-6, TNF-
a and TGF-b under environmental stress to remove
injured cells and recruit healthy cells [43]. However,
there is no report indicating the correlation between
rECP and TNF-a liberation. Trautmann et al. found
that IFN-g stimulated eosinophil lysate induced bron-
chial epithelial cells to undergo apoptosis [24] TNF-a
played an important role in IFN-g stimulated eosino-
phil-induced apoptosis in bronchial epithelial cells, as
evidenced by TNF-a antibody blocking experiment.
Besides, previous study showed that co-culture with
house dust mite-activated eosinophils and airway bron-
chial epithelial cells induced TNF-a release; the inhibi-
tion experiment further indicated that p38 MAPK and
NF-Bw e r ei n v o l v e di nT N F - a release in eosinophil-
AECs system [58]. Since ECP is the major component
in eosinophils, it is possible that rECP induced TNF-a
production may also involve NF-Ba n dM A P Kp a t h -
ways. Here we hypothesized that up-regulated TNF-a,
triggered by rECP treatment, was released to external
environment, where it killed cells via a feedback
mechanism. In this way, the death receptor-triggered
pathway would be stimulated to promote apoptosis. As
a result, ECP might be recognized by cells as portending
pathogen invasion, thereby inducing certain immune
responses such as cytokine production and apoptosis. In
this study, it found that the inactive RNase, mECP,
could still induce TNF-a production, but highly active
RNase A showed no significant TNF-a production,
strongly suggesting that RNase activity did not corre-
lated with TNF-a production (Additional file 3).
TNF-a receptor activation triggered apoptosis can
undergo either mitochondria-dependent pathway which
is involved in tBid activation and triggers caspase-9 acti-
vation by releasing cytochrome c, or mitochondria-inde-
pendent pathway [59]. In our study, caspase-9 inhibitor,
MMP assays and cytochrome c release experiments all
i n d i c a t e dt h a tr E C Pd i dn o ti n d u c em i t o c h o n d r i a l
response, hence the apoptosis underwent mitochondria-
independent pathway. Previous study has reported that
caspase-6 is able to activate caspase-8 and involved in
mitochondrial response [60]. However, it was proved
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drial response; hence we speculated that caspase-8 was
activated by TNFR pathway instead of caspase-6. Taken
together, Figure 8 presents that ECP induces apoptosis
involved in TNF-a-related caspase-8 activation through
mitochondria-independent pathway.
Although ECP belongs to the pancreatic-type RNase
family [6], its RNase activity is relatively weak. More-
over, the RNase activity of ECP is not essential for its
cytotoxicity [13]. ECP, EDN, and RNase A (RNase 1) all
belong to the pancreatic RNase family, and their RNase
activities can be detected (Additional file 4). As illu-
strated in our additional file 5, ECP and mutant rECP
H15A/K38I/H128A with low or no RNase activity have
higher toxicity toward BEAS-2B cells, whereas EDN and
R N a s eAw i t hh i g hR N a s ea c t i v i t ys h o wn ot o x i c i t y
toward BEAS-2B cells. Accordingly, our study also con-
firms that rECP lacking of RNase activity retains cyto-
toxicity. On the contrary, human RNase A is highly
enzymatically active in RNA degradation but has no
cytotoxicity. Therefore, we suggest that the cytotoxicity
of ECP is not correlated to the RNase activity.
Onconase (ONC), one member of bullfrog RNase A
superfamily, displays apoptosis to tumor cells via cas-
pase-9 dependent but caspase-8 independent pathway
[23]. Different from ONC, in this study, ECP triggers
apoptosis via caspase-8 dependent but caspase-9 inde-
pendent pathway. Recently, ONC was found to enter
cells by clathrin-dependent endocytosis [61]. However,
ECP endocytosed into BEAS-2B cells by non-clathrin
but lipid raft-dependent macropinocytosis [19]. Accord-
ingly, we speculate that the mechanisms of toxic RNase
endocytosis may activate different caspase pathways in
target cells.
ECP endocytosis into BEAS-2B cells are facilitated by
HSPGs [19]. Interestingly, HS was also detected on the
surface of A549 cells (lung carcinoma cells) [62]. Conse-
quently, we found that rECP could induce apoptosis in
A549 cells too (data not shown). Taken together, HS
plays an important role in toxin endocytosis and trigger-
ing apoptosis in lung epithelial cells. Through specific
interaction between ECP and HS, ECP can target cancer
cells that are rich in HS [63]. Our results suggest that
ECP-induced apoptosis might provide novel therapies
for specific cancer cells.
Conclusions
In summary, we found that rECP could inhibit BEAS-2B
cell viability and induce apoptosis. Increase of TNF-a in
cells and medium, as well as cleavage of caspase-8 in
BEAS-2B cells were detected after rECP treatment.
However, neither MMP nor ER response was observed
in the rECP-induced apoptotic cells. In addition, cas-
pase-9 and -12 inhibitor assays confirmed such
Figure 8 Role of rECP in TNF-a apoptosis signaling.r E C P
increases BEAS-2B cells TNF-a production and release. The release
of TNF-a binding to TNF receptor results in receptor internalization
and activates caspase-8. Caspase-8-induced apoptosis can either
trigger mitochondrial response or directly cause PARP activation by
caspase-3. However, rECP-induced apoptosis shows no effects on
mitochondrial responses. Accordingly, we suggest that rECP induces
mitochondria-independent apoptosis.
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Page 9 of 14speculation. Thus, we clearly demonstrate that rECP
causes BEAS-2B cell apoptosis mainly through TNF-a-
mediated caspase-8 specific pathway in a mitochondria-
independent manner. The knowledge of this molecular
basis is pivotal in understanding the development of
pathogenesis in asthma and shed a light on potential
therapeutic applications.
Methods
Cell and cell culture
BEAS-2B cells purchased from American Type Culture
Collection (ATCC) were maintained in RPMI-1640
medium (Sigma-Aldrich) supplemented with heat-inacti-
vated 10% fetal calf serum (Gibco/Invitrogen), 100 U/ml
penicillin, and 100 μg/ml streptomycin sulfate. Cells
were maintained in 9-cm culture dishes with 5% CO2 at
37°C. Cells were sub-seeded in appropriate culture ves-
sels (6- or 12-well plates) and incubated at 37°C for 24
h prior to all treatments.
Expression and purification of rECP and mutant ECP
Both recombinant ECP (rECP) and H15A/K38I/H128A
mutant rECP (mECP) were expressed in Escherichia coli
and purified as described [64] with minor modification.
rECP and mECP containing a C-terminal His6 tag were
expressed in E. coli BL21(DE3) (Novagen) and purified
by affinity column chromatography (BD Biosciences).
For each preparation, 10 ml of overnight culture was
inoculated into 1 L LB containing 100 μg/ml ampicillin,
and grown at 37°C for 6 h. Isopropyl-b-D-thiogalacto-
pyranoside (IPTG, Sigma-Aldrich) was added to a final
concentration of 0.5 mM, and after induction at 37°C
for 6 h, the E. coli was harvested by centrifugation at
3000 rpm. rECP and mECP were collected from inclu-
sion bodies that were refolded by dialysis in refolding
buffer (20 mM Tris, 0.5 M arginine, 0.2 mM GSSG, 2
mM EDTA, 10% glycerol, pH 8.5). The purified rECP
and mECP were concentrated by Amicon Ultra-15
(Millipore) and stored in phosphate-buffered saline
(PBS) at -80°C until use. After purification, we used
Endotoxin Removing Gel (Pierce) to remove LPS before
rECP storage and also checked LPS residual level by
HEK-Blue™ LPS Detection Kit (InvivoGen) before each
treatment.
MTT cell viability assay
The toxicity effect of rECP on cell viability was deter-
mined by a colorimetric assay using 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltertrazolium bromide (MTT)
(Sigma-Aldrich) as described [65]. Briefly, cells
(5,000~10,000) were seeded in 96-well plate and incu-
bated overnight at 37°C, 5% CO2. The cells were treated
with the indicated concentration (up to 40 μM) of rECP.
After treatment with rECP for 48 h, 10 μl MTT (5 mg/
ml in PBS) was added to 90 μl of culture medium/well
for 4 h. Levels of MTT were determined by measuring
the absorbance at 570 nm.
Detection of chromatin condensation
Hoechst 33342 (1 μg/ml) (Sigma-Aldrich) was added 20
min prior to the end of the incubation period in the
dark. The cells were washed with cold PBS twice and
fixed with 3.7% formaldehyde for 15 min. The nuclei of
apoptotic cells were observed by fluorescence
microscopy.
Detection of apoptosis by sub-G1 fractions and Annexin-
V-FITC
To determine the sub-G1 fractions, detached BEAS-2B
cells were fixed in 75% ethanol at -20°C overnight and
centrifuged at 1000 × g for 5 min to remove ethanol,
followed by treatment with 50 μg/ml RNase A and
staining with 50 μg/ml propidium iodide (PI) (Sigma-
Aldrich) on ice for 30 min in the dark [66]. The stained
cells were analyzed by fluorescence-activated cell sorting
(FACS) (Becton Dickinson) according to the manufac-
turer’s instructions. The levels of early apoptosis were
determined using the Annexin-V-FITC Apoptosis
Detection kit (BD Biosciences). The method was per-
formed as described [67] with minor modification. After
trypsinization, BEAS-2B cells were washed twice with
cold PBS and resuspended in 1× binding buffer. The cell
suspension (200 μl) was transferred to 5-ml tubes, and 5
μl annexin V was added. After incubation with annexin
Vf o r5m i na t4 ° C ,5μl PI was added. The cells were
i n c u b a t e da t4 ° Ci nt h ed a r kf o r1 5m i n ,a n d8 0 0μlo f
binding buffer (10 mM HEPES, pH 7.4, 140 mM NaCl,
2.5 mM CaCl2) was added before FACS analysis.
Detection of mitochondrial membrane potential (MMP)
To determine MMP, the detached BEAS-2B cells were
stained with 100 nM MitoTracker Red CMXRos (Mole-
cular Probes) in RPMI medium for 20 min at 37°C in
the dark. After typsinization, the stained cells were ana-
lyzed by FACS. Fluorescence of PI was collected in the
FL2 or FL3 detector, and fluorescence of MitoTracker
was collected in the FL3 detector. All data were evalu-
ated using Cell Quest software (Becton Dickinson).
Caspase and TNF-a inhibitors treatment
Benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (Z-
VAD-FMK) (Calbiochem), benzyloxycarbonyl-Ile-Glu-
Thr-Asp-fluoromethylketone (Z-IETD-FMK) (Calbio-
chem), benzyloxycarbonyl-Leu-Glu(OMe)-His-Asp
(OMe)-fluoromethylketone (Z-LE(OMe)HD(OMe)-
FMK) (Calbiochem), and benzyloxycarbonyl-Ala-Thr-
Ala-Asp-fluoromethylketone (Z-ATAD-FMK) (BioVi-
sion) are irreversible cell-permeable inhibitors of the
general caspase pathway, caspase-8-, caspase-9- and cas-
pase-12-specific pathways, respectively [68]. For studies
concerning the effect of inhibitors, each inhibitor (stored
in 10 mM DMSO) was added to BEAS-2B cells at 20
μM for 30 min prior to the addition of rECP.
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treated with rECP neutralized with/without anti-TNF-a
antibody (Ab) (5 μg/ml; Abcam). The addition of poly-
clonal rabbit IgG Ab (5 μg/ml; Sigma-Aldrich) to the
m e d i u mo fc e l l sw a su s e da sc o n t r o l si ni n h i b i t o rs t u -
dies. The dose of the inhibitors was used in the informa-
tion based on the efficacy in the inhibition of the
activity of the cytokines but not cause cytotoxicity (try-
pan blue dye exclusion).
Western blotting
BEAS-2B cells treated with rECP neutralized with/with-
out the inhibitors. Cell lysates were homogenized by
sample buffer (100 mM Tris-HCl (pH 6.8), 2% Sodium
Dodecyl Sulfate (SDS), 0.002% bromophenol blue, 20%
glycerol, 10% b-mercaptoethanol (all from Sigma-
Aldrich). Those were subjected to SDS-PAGE and trans-
ferred onto nitrocellulose membranes (Amersham Bios-
ciences). The following primary antibodies were used for
immunodetection: rabbit anti-human poly(ADP-ribose)
polymerase (PARP) (Cell Signaling), goat anti-human
actin (Santa Cruz Biotechnology), mouse anti-human
caspase-8 (Calbiochem), and rat anti-human GRP78
(Santa Cruz Biotechnology). Secondary antibodies conju-
gated to horseradish peroxidase (Santa Cruz Biotechnol-
ogy) and the Western Blot Substrate kit (Pierce) were
used to detect chemiluminescence.
De novo protein synthesis
Metabolic labeling of nascent proteins was conducted as
described [69]. At the end of various treatment periods,
the cells were washed with PBS twice, and replaced with
RPMI medium containing [
35S]methionine (20 μCi/ml)
for 2 h. After removal of the medium, the cells were
washed with PBS twice and lysed with 2× sample buffer.
Equal amounts of cells were heated at 100°C in sample
buffer for 10 min and resolved by SDS-PAGE. The gel
was dried for 2 h and exposed to X-ray film for 4 days
before development.
Quantitative measurement of TNF-a
For determination of cell-associated cytokine concentra-
tions, cell lysate was prepared using protein extract buf-
fer containing 0.6 M KCl, 1% Triton X-100, 0.02 M
Tris-HCl (pH7.0), 1.0 mM phenylmethylsufonyl fluoride,
and 50 μg/ml aprotinin (all from Sigma-Aldrich). After
centrifugation at 9,500 g for 3 min at 4°C, protein sam-
ples in the supernatant were immediately transferred to
a clean tube, and the concentration assessed using DC
protein assay kit (Bio-Rad). Supernatant and lysate TNF-
a concentrations were determined using corresponding
ELISA Ready-SET-Go kits (eBioscience) and expressed
in pictograms of TNF-a per milligram of cellular pro-
tein. The optical density was detected using a VERSA-
max microplate reader (Molecular Devices) and the
levels of each cytokine were deduced from the
absorbance value by extrapolation from a standard
curve generated in parallel.
DNA fragmentation
DNA fragmentation assay was conducted as described
[70] with minor modification. Cells were washed twice
in cold PBS and resuspended in 100 ml of lysis buffer
(10 mM Tris-HCl, pH8, 1 mM EDTA, pH 8.0, 0.5%N-
lauroyl sarcosine, 0.02 mg/ml RNAse A, and 0.25 mg/ml
proteinase K). After incubation for 10 min at 55°C, the
sample was loaded into the 2% agarose gel. Electrophor-
esis was then performed in TBE buffer (89 mM Tris-
base, 89 mM boric acid, 2 mM EDTA pH 8.0).
Cytochrome C release detection
Cytochrome C release detection assay was followed as
described [70] with minor modification. Cells were put
on ice for 10 min and washed twice in cold PBS. Cell
pellets were then resuspended in 250 ml of buffer A (75
mM KCl, 1 mM Na2HPO4,8m MN a 2HPO4, 250 mM
sucrose, 230 mg/ml digitonin) and incubated on ice for
10 min. After centrifugation at 15,000 g for 10 min at 4°
C, supernatant were kept to obtain the cytosolic frac-
tions. The cytosolic fraction was mixed with an equal
volume of 2× RIPA buffer (1× RIPA is 1% IGEPAL,
0.5% sodium deoxycholate, 0.1% SDS, 0.2 mM sodium
orthovanadate, 50 mM sodium fluoride, 0.1 mg/ml phe-
nyl methyl sulfonyl fluoride).
Ribonuclease assay
The RNase activity of the recombinant proteins against
a yeast tRNA (Sigma-Aldrich) substrate was measured
in 20 mM Tris-HCl buffer (pH 8.0) at 37°C. Purified
RNase (30 pmol) was added into 50 μl of the Tris buffer
with 120 μg of tRNA. The reaction was stopped by addi-
tion of 200 μl 0.7% perchloric acid with 0.1% uranyl
acetate and incubated on ice for 30 min. The insoluble
tRNA was removed by centrifugation at 14,000 g for 15
min at 4°C. The amount of solubilized tRNA was deter-
mined by UV absorbance at 260 nm. The catalytic activ-
ity of the RNase was determined as the nanogram of
RNA digested per second per nanomol of RNase used.
Statistical analysis
Results were described as mean ± standard deviation.
All statistical analysis was conducted by the statistical
package SPSS13.0. The differences were investigated
using Student’s t-test and one-way analysis of variance
(ANOVA). Values of P are considered to be statistically
significant: *P < 0.05, **P < 0.01; ***P < 0.001.
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methylketone; Z-VAD-FMK: Benzyloxycarbonyl-Val-
Ala-Asp-fluoromethyl-ketone; Z-ATAD-FMK: benzylox-
ycarbonyl-Ala-Thr-Ala-Asp-fluoro-methylketone.
Additional file 1: Supplementary Figure 1. rECP induces DNA
fragmentation in BEAS-2B cells. BEAS-2B cells (5 × 10
5) were incubated
in a 10 cm dish in the absence or presence of 20 μM of rECP for 48 h.
DNA damage indicating apoptosis was determined by the DNA
fragmentation.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2121-11-6-
S1.TIFF]
Additional file 2: Supplementary Figure 2. Effect of cytochrome c
release on rECP treatment. BEAS-2B cells (5 × 10
4) were incubated in a
6 well plate in the absence or presence of 10, 20 μM of rECP for 24 h.
The cytosolic cytochorme c was detected by western blotting.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2121-11-6-
S2.TIFF]
Additional file 3: Supplementary Figure 3. Effects of TNF-a
liberation on various RNases. BEAS-2B cells were treated with 20 μM
RNase A, rECP and mECP. TNF-a was measured in cell lysates by
treatment for 48 h. All the TNF-a measurements were determined by
ELISA assay. All data represent the arithmetic mean ± SEM. *P < 0.05
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2121-11-6-
S3.TIFF]
Additional file 4: Supplementary Figure 4. RNase activities of
recombinant eosinophil RNases degrading yeast tRNAs. The RNase
activities of rECP and EDN were measured employing a standard assay
with yeast tRNA as the substrate, and RNaseA as a positive control. The
values indicate in nmol tRNA digested per pmol enzyme per second.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2121-11-6-
S4.TIFF]
Additional file 5: Supplementary Figure 5. Effect of different
ribonucleases on cytotoxicity of BEAS-2B cells. Equal mounts of cells
were cultured in 12-well plates in the presence of 20 μM of rECP, mutant
rECP, rEDN and RNase A for 48 h. The cleavage of PARP was detected by
western blotting. *P < 0.05
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2121-11-6-
S5.TIFF]
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